A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
von Willebrand Panel
Test Code91242
CPT Codes
85240, 85246, 85245, 85730
Includes
Factor VIII Activity, Clotting
von Willebrand Factor Antigen
Ristocetin Cofactor
Partial Thromboplastin Time, Activated
von Willebrand Factor Antigen
Ristocetin Cofactor
Partial Thromboplastin Time, Activated
Preferred Specimen
3.6 mL platelet-poor plasma collected in 3.2% sodium citrate (light blue-top) tube
Minimum Volume
1.8 mL
Instructions
See individual assays
Transport Temperature
Frozen
Specimen Stability
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 14 days
Refrigerated: Unacceptable
Frozen: 14 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Hemolysis • Lipemia
Methodology
Immunoturbidimetric Assay • Photometric Clot Detection • Photo-Optical Clot Detection • Platelet Agglutination
Setup Schedule
See individual assays
Clinical Significance
von Willebrand Disease (VWD) is the most common hereditary bleeding disorder and it may also be acquired. von Willebrand Factor (VWF) is critical for normal hemostasis; mediating platelet adhesion to the damaged endothelium and protecting Factor VIII from proteolytic degradation in circulation. Types 1 and 3 VWD are characterized by a decrease in both VWF quantitative and functional assays, whereas type 2 variants are characterized by defects in functional assays or VWF multimeric studies. Because of the numerous variants of VWD which may have different treatments, multiple assays are often necessary to identify the type of VWD.